-
-
-
-
-
-
-
Kinnate Biopharma (KNTE) Adds Two New Drug Candidates to Its Growing Targeted Oncology Pipeline and Provides Cash Runway Guidance
-
-
-
-
-
-
-
Kinnate Biopharma Inc. Reports Third Quarter 2021 Financial Results
-
-
-
975,717 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All